![]() However, in spite of the well-established fundamental mechanisms that induce dyspnoea in healthy individuals and patients with COPD, as well as the proven effectiveness of multiple and varied therapeutic interventions in reducing dyspnoea in such patients, the clinical evaluation and quantification of dyspnoea remain imprecise. The objective of improving dyspnoea is supreme in the management of COPD as few therapeutic interventions are disease-modifying in curtailing the underlying problem of accelerated loss of lung function leading to premature disability or death. Therefore, alleviating dyspnoea is a primary treatment goal for most patients with stable COPD. Dyspnoea is the most common and troubling symptom in patients with chronic obstructive pulmonary disease (COPD) and the severity of the symptom engenders negative impacts on health status, exacerbation rate, healthcare resource utilization and prognosis.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |